Overview

Protein Engineering Market is forecasted to value over USD 4.8 billion by 2027 end and register a CAGR of 12.3% from the forecast period 2020-2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Protein Engineering Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis of market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.
According to the research study conducted by FutureWise research analysts, the Protein Engineering Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the Protein Engineering Market along with the growth opportunities present across this business vertical.

Major players included in the Protein Engineering Market are:    
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Bruker Corporation
• Agilent Technologies, Inc.
• Waters Corporation
• Danaher Corporation
• Codexis, Inc.
• New England Biolabs, Inc.
• PerkinElmer
• Innovagen AB
• GE Healthcare
• CUSABIO TECHNOLOGY LLC
• Promega Corporation
• Merck KGaA
• GenScript Biotech Corporation
• Takara Bio, Inc.
• Enantis S.R.O
• InvivoGen
• Pace Analytical
• Aspira Chemical
(Note: The list of the major players will be updated with the latest market scenario and trends)

Protein Engineering Market Segmentation:

By Product & Service

• Instruments
• Consumables
• Software & Services

By Protein Type

• Monoclonal Antibodies
• Erythropoietin
• Interferons
• Vaccines
• Colony-stimulating Factors
• Growth Hormones
• Coagulation Factors
• Others

By Technology

• Rational Protein Design
• Irrational Protein Design

By End User

• Biopharmaceutical Companies
• Contract Research Organizations
• Academic Research Institutes

By Region
• North America
• Europe
• Asia-Pacific
• Rest of the world

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Protein Engineering Market by product & service, by protein type, by technology, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction

1.1 Objectives of the Study 

1.2 Market Definition 

1.3 Market Scope 

               1.3.1 Years Considered for the Study

                1.3.2 Market Covered                  

1.4 Currency   

1.5 Limitations 

1.6 Stakeholders 

2.  Research Methodology 

2.1 Research Data 

         2.1.1 Secondary Data

                 2.1.1.1 Key Data From Secondary Sources

         2.1.2 Primary Data

                 2.1.2.1 Key Data From Primary Sources

2.2 Market Size Estimation 

2.3 Market Breakdown and Data Triangulation 

2.4 Assumptions for the Study  

3. Executive Summary

        3.1 Market Outlook

        3.2 Segment Outlook

        3.3 Competitive Insights

4. Global Protein Engineering Market Variables, Trends & Scope

       4.1. Market Lineage Outlook

       4.2. Penetration and Growth Prospect Mapping

       4.3. Industry Value Chain Analysis

       4.4. Cost Analysis Breakdown

       4.5. Technology Overview

       4.6. Regulatory Framework

                 4.6.1. Reimbursement Framework

                 4.6.2. Standards And Compliances

5. Market Overview

     5.1. Market Dynamics

                  5.1.1. Market Driver Analysis

                            5.1.1.1. Increasing focus on Brand Protection

                            5.1.1.2. Untapped Opportunities in Emerging Regions

                  5.1.2. Market Restraint Analysis

                  5.1.3. Industry Challenges

                            5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Protein Engineering Market Analysis Tools

         6.1. Industry Analysis - Porter’s

               6.1.1. Supplier Power

               6.1.2. Buyer Power

               6.1.3. Substitution Threat

               6.1.4. Threat from New Entrants

               6.1.5. Competitive Rivalry

         6.2. Pestel Analysis

               6.2.1. Political Landscape

               6.2.2. Environmental Landscape

               6.2.3. Social Landscape

               6.2.4. Technology Landscape

               6.2.5. Legal Landscape

         6.3. Major Deals And Strategic Alliances Analysis

                6.3.1. Joint Ventures

                6.3.2. Mergers and Acquisitions

                6.3.3. Licensing and Partnership

                6.3.4. Technology Collaborations

                6.3.5. Strategic Divestments

         6.4. Market Entry Strategies

         6.5. Case Studies

7. Global Protein Engineering Market, By Product & Service Historical Analysis and Forecast 2020-2027 (USD Million)

         7.1. Instruments

         7.2. Consumables

         7.3. Software & Services

8. Global Protein Engineering Market, By Protein Type Historical Analysis and Forecast 2020-2027 (USD Million)

         8.1. Monoclonal Antibodies

         8.2. Erythropoietin

         8.3. Interferons

         8.4. Vaccines

         8.5. Colony-stimulating Factors

         8.6. Growth Hormones

         8.7. Coagulation Factors

         8.8. Others

9. Global Protein Engineering Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)

         9.1. Rational Protein Design

         9.2. Irrational Protein Design

10. Global Protein Engineering Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)

         10.1. Biopharmaceutical Companies

         10.2. Contract Research Organizations

         10.3. Academic Research Institutes

11.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs

     11.1. Introduction

     11.2. Historical Market Size (USD Million) Analysis By Country, 2015-20111

            11.2.1. U.S.A

            11.2.2. Canada

            11.2.3. Mexico

     11.3. Market Size (USD Million) Forecast for North America 2020-2027

12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

     12.1. Introduction

     12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019

           12.2.1. Germany

           12.2.2. U.K

           12.2.3. France

           12.2.4. Italy

           12.2.5. Spain

           12.2.6. Russia

           12.2.7. Poland

           12.2.8. Switzerland

           12.2.9. Rest of Western Europe

13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along with expected regulatory needs

        13.1. Introduction

        13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 

             13.2.1. Japan

             13.2.2. China

             13.2.3. Singapore

             13.2.4. India

             13.2.5. Australia and New Zealand

             13.2.6. ASEAN

             13.2.7. South Korea

             13.2.8. Rest of Asia Pacific

        13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027

14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

         14.1. Introduction

         14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019

                   14.2.1. Saudi Arabia

                   14.2.2. UAE

                   14.2.3. South Africa

                   14.2.4. Egypt

         14.3. Market Size (USD Million) Forecast for MEA 2020-2027

15. Rest of the World Market Analysis 2015–2019 and Forecast

         2020–2027 (USD Million) along with expected regulatory needs

        15.1. Introduction

        15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019

             15.2.1. Saudi Arabia

             15.2.2. UAE

             15.2.3. South Africa

             15.2.4. Egypt

        15.3. Market Size (USD Million) Forecast for MEA 2020-2027          

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    16.1. Bio-Rad Laboratories, Inc.
          16.1.1. Company Overview
          16.1.2. Product Portfolio
          16.1.3. SWOT Analysis
          16.1.4. Financial Overview
          16.1.5. Strategic Overview
    16.2. Thermo Fisher Scientific, Inc.
          16.2.1. Company Overview
          16.2.2. Product Portfolio
          16.2.3. SWOT Analysis
          16.2.4. Financial Overview
          16.2.5. Strategic Overview 
    16.3. Bruker Corporation
          16.3.1. Company Overview
          16.3.2. Product Portfolio
          16.3.3. SWOT Analysis
          16.3.4. Financial Overview
          16.3.5. Strategic Overview
    16.4. Agilent Technologies, Inc.
          16.4.1. Company Overview
          16.4.2. Product Portfolio
          16.4.3. SWOT Analysis
          16.4.4. Financial Overview
          16.4.5. Strategic Overview
    16.5. Waters Corporation
          16.5.1. Company Overview
          16.5.2. Product Portfolio
          16.5.3. SWOT Analysis
          16.5.4. Financial Overview
          16.5.5. Strategic Overview          
    16.6. Danaher Corporation
          16.6.1. Company Overview
          16.6.2. Product Portfolio
          16.6.3. SWOT Analysis
          16.6.4. Financial Overview
          16.6.5. Strategic Overview      
    16.7. Codexis, Inc.
          16.7.1. Company Overview
          16.7.2. Product Portfolio
          16.7.3. SWOT Analysis
          16.7.4. Financial Overview
          16.7.5. Strategic Overview
    16.8. New England Biolabs, Inc.
          16.8.1. Company Overview
          16.8.2. Product Portfolio
          16.8.3. SWOT Analysis
          16.8.4. Financial Overview
          16.8.5. Strategic Overview 
    16.9. PerkinElmer
          16.9.1. Company Overview
          16.9.2. Product Portfolio
          16.9.3. SWOT Analysis
          16.9.4. Financial Overview
          16.9.5. Strategic Overview 
    16.10.Innovagen AB
          16.10.1. Company Overview
          16.10.2. Product Portfolio
          16.10.3. SWOT Analysis
          16.10.4. Financial Overview
          16.10.5. Strategic Overview
    16.11.GE Healthcare
          16.11.1. Company Overview
          16.11.2. Product Portfolio
          16.11.3. SWOT Analysis
          16.11.4. Financial Overview
          16.11.5. Strategic Overview          
    16.12.CUSABIO TECHNOLOGY LLC
          16.12.1. Company Overview
          16.12.2. Product Portfolio
          16.12.3. SWOT Analysis
          16.12.4. Financial Overview
          16.12.5. Strategic Overview      
    16.13.Promega Corporation
          16.13.1. Company Overview
          16.13.2. Product Portfolio
          16.13.3. SWOT Analysis
          16.13.4. Financial Overview
          16.13.5. Strategic Overview
    16.14.Merck KGaA
          16.14.1. Company Overview
          16.14.2. Product Portfolio
          16.14.3. SWOT Analysis
          16.14.4. Financial Overview
          16.14.5. Strategic Overview
    16.15.GenScript Biotech Corporation
          16.15.1. Company Overview
          16.15.2. Product Portfolio
          16.15.3. SWOT Analysis
          16.15.4. Financial Overview
          16.15.5. Strategic Overview
    16.16.Takara Bio, Inc.
          16.16.1. Company Overview
          16.16.2. Product Portfolio
          16.16.3. SWOT Analysis
          16.16.4. Financial Overview
          16.16.5. Strategic Overview      
    16.17.Enantis S.R.O
          16.17.1. Company Overview
          16.17.2. Product Portfolio
          16.17.3. SWOT Analysis
          16.17.4. Financial Overview
          16.17.5. Strategic Overview
    16.18.InvivoGen
          16.18.1. Company Overview
          16.18.2. Product Portfolio
          16.18.3. SWOT Analysis
          16.18.4. Financial Overview
          16.18.5. Strategic Overview
    16.19.Pace Analytical
          16.19.1. Company Overview
          16.19.2. Product Portfolio
          16.19.3. SWOT Analysis
          16.19.4. Financial Overview
          16.19.5. Strategic Overview      
    16.20.Aspira Chemical
          16.20.1. Company Overview
          16.20.2. Product Portfolio
          16.20.3. SWOT Analysis
          16.20.4. Financial Overview
          16.20.5. Strategic Overview

17. FutureWise SME key takeaway points for Client

Tables

Figures